ZA983608B - Leptin as an inhibitor of tumor cell proliferation - Google Patents

Leptin as an inhibitor of tumor cell proliferation

Info

Publication number
ZA983608B
ZA983608B ZA983608A ZA983608A ZA983608B ZA 983608 B ZA983608 B ZA 983608B ZA 983608 A ZA983608 A ZA 983608A ZA 983608 A ZA983608 A ZA 983608A ZA 983608 B ZA983608 B ZA 983608B
Authority
ZA
South Africa
Prior art keywords
leptin
inhibitor
cell proliferation
tumor cell
tumor
Prior art date
Application number
ZA983608A
Other languages
English (en)
Inventor
Dalit Barkan
Batya Cohen
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA983608B publication Critical patent/ZA983608B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2264Obesity-gene products, e.g. leptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA983608A 1997-04-29 1998-04-29 Leptin as an inhibitor of tumor cell proliferation ZA983608B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12073397A IL120733A0 (en) 1997-04-29 1997-04-29 Leptin as an inhibitor of cell proliferation

Publications (1)

Publication Number Publication Date
ZA983608B true ZA983608B (en) 1998-11-02

Family

ID=11070075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983608A ZA983608B (en) 1997-04-29 1998-04-29 Leptin as an inhibitor of tumor cell proliferation

Country Status (26)

Country Link
US (1) US7109159B1 (ko)
EP (1) EP0981365B1 (ko)
JP (1) JP4330662B2 (ko)
KR (1) KR100507731B1 (ko)
CN (1) CN1168497C (ko)
AR (1) AR012626A1 (ko)
AT (1) ATE283702T1 (ko)
AU (1) AU742927B2 (ko)
BG (1) BG63490B1 (ko)
CA (1) CA2288238A1 (ko)
CZ (1) CZ299872B6 (ko)
DE (1) DE69827942T2 (ko)
EA (1) EA002353B1 (ko)
EE (1) EE04801B1 (ko)
ES (1) ES2232944T3 (ko)
HK (1) HK1028350A1 (ko)
HU (1) HUP0002427A3 (ko)
IL (2) IL120733A0 (ko)
NO (1) NO322304B1 (ko)
NZ (1) NZ500589A (ko)
PL (1) PL195275B1 (ko)
PT (1) PT981365E (ko)
SK (1) SK284848B6 (ko)
UA (1) UA66793C2 (ko)
WO (1) WO1998048831A1 (ko)
ZA (1) ZA983608B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) * 1999-09-05 2001-03-19 Yeda Res & Dev Use of leptin in inhibition of endothelial cell proliferation
EP2422807A3 (en) 2004-02-11 2012-05-30 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
US7863240B2 (en) * 2004-10-08 2011-01-04 Enzo Therapeutics, Inc. Methods and uses of leptin in hepatocellular carcinoma
US20090286723A1 (en) 2005-02-11 2009-11-19 Amylin Pharmaceuticals, Inc. Hybrid Polypeptides with Selectable Properties
KR20070115947A (ko) 2005-02-11 2007-12-06 아밀린 파마슈티칼스, 인크. 선택가능한 특성들을 가지는 gip 유사체 및 하이브리드폴리펩타이드
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
US8716220B2 (en) * 2005-09-07 2014-05-06 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8642543B2 (en) * 2005-09-07 2014-02-04 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
CA2712606A1 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
TWI752920B (zh) 2015-10-12 2022-01-21 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
AU2017359439A1 (en) 2016-11-08 2019-05-23 Regeneron Pharmaceuticals, Inc. Antigen-binding proteins that antagonize leptin receptor
AU2018390811A1 (en) 2017-12-18 2020-07-02 Regeneron Pharmaceuticals, Inc. Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
EP3773713A1 (en) 2018-04-06 2021-02-17 Regeneron Pharmaceuticals, Inc. A leptin receptor agonist antibody for use in treating a metabolic dysfunction or hypoleptinemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002004A2 (en) * 1995-06-30 1997-01-23 Eli Lilly And Company Methods for treating diabetes
EP0764722A2 (en) * 1995-09-19 1997-03-26 Eli Lilly And Company DNA encoding primate leptins as medicinal proteins
EP0892849B1 (en) * 1996-01-23 2006-03-15 Indevus Pharmaceuticals, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development

Also Published As

Publication number Publication date
AU7076298A (en) 1998-11-24
DE69827942T2 (de) 2005-12-08
ATE283702T1 (de) 2004-12-15
AR012626A1 (es) 2000-11-08
EP0981365B1 (en) 2004-12-01
HUP0002427A2 (hu) 2000-12-28
IL120733A0 (en) 1997-08-14
NO995267D0 (no) 1999-10-28
NZ500589A (en) 2001-03-30
HK1028350A1 (en) 2001-02-16
KR20010012080A (ko) 2001-02-15
CA2288238A1 (en) 1998-11-05
CZ384899A3 (cs) 2000-06-14
BG103832A (en) 2000-10-31
PL195275B1 (pl) 2007-08-31
US7109159B1 (en) 2006-09-19
EE04801B1 (et) 2007-04-16
BG63490B1 (bg) 2002-03-29
JP4330662B2 (ja) 2009-09-16
NO322304B1 (no) 2006-09-11
DE69827942D1 (de) 2005-01-05
UA66793C2 (uk) 2004-06-15
CN1261802A (zh) 2000-08-02
AU742927B2 (en) 2002-01-17
NO995267L (no) 1999-12-28
JP2001524968A (ja) 2001-12-04
ES2232944T3 (es) 2005-06-01
CZ299872B6 (cs) 2008-12-17
EP0981365A1 (en) 2000-03-01
IL132633A (en) 2007-07-04
PT981365E (pt) 2005-03-31
PL336582A1 (en) 2000-07-03
SK147199A3 (en) 2000-06-12
WO1998048831A1 (en) 1998-11-05
SK284848B6 (sk) 2006-01-05
KR100507731B1 (ko) 2005-08-10
EA002353B1 (ru) 2002-04-25
EE9900510A (et) 2000-06-15
HUP0002427A3 (en) 2003-02-28
CN1168497C (zh) 2004-09-29
EA199900981A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
ZA983608B (en) Leptin as an inhibitor of tumor cell proliferation
EP0934404A4 (en) INHIBITION OF CELL PROLIFERATION
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
EP0971723A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EG24027A (en) Pyrrolotriazine inhibitors of kinases
PL339738A1 (en) Novel lactamic inhibitors of metaloproteinases
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
EP1119365A4 (en) COMPOSITIONS AND METHODS FOR USING TUMOR CELLS
PL342964A1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
PL337091A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU9312598A (en) Inhibitors of collagen assembly
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU3459497A (en) Cancer cell proliferation inhibitors
IL132633A0 (en) Leptin as an inhibitor of tumor cell proliferation
SI0981365T1 (en) Leptin as an inhibitor of tumor cell proliferation
AU8492598A (en) Methods and compositions for tumor reduction
PL336896A1 (en) Cyanoamidines as inhibitors of cell proliferation
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU2086597A (en) Inhibition of proliferation of cells
AUPO186196A0 (en) Inhibition of cellular proliferation
EP0846765A4 (en) CELL PROLIFERATION INHIBITOR